ACIU
AC Immune SA
NASDAQ · Healthcare · Biotechnology · CH
$2.63
−1.87%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- 10.96x
- P/E 2028E
- 5.99x
- P/S forward
- 28.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.13x
- Price / sales
- 12.31x
- Price / cash flow
- -6.20x
Enterprise value
- Enterprise value
- $175.1M
- EV / sales
- 8.24x
- EV / EBITDA
- -3.44x
- EV / EBIT
- -3.27x
- Market cap
- $261.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026